Ashburton (Jersey) LTD Amgen Inc Transaction History

Ashburton (Jersey) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Apr 26, 2023	SELL	$224.46 - $253.15 $16,385 - $18,479	-73 Closed	0 $0
Q2 2021 May 26, 2023	SELL	$233.58 - $259.14 $17,051 - $18,917	-73 Closed	0 $0
Q1 2021 May 26, 2023	BUY	$221.91 - $258.6 $16,199 - $18,877	73 New	73 $18,000
Q4 2020 May 23, 2023	BUY	$216.38 - $257.67 $15,795 - $18,809	73 New	73 $17,000
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $26,704 - $32,769	-135 Reduced 64.9%	73 $17,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $3,594 - $4,620	-19 Reduced 8.37%	208 $50,000
Q2 2019 Jul 26, 2019	BUY	$166.7 - $195.41 $37,840 - $44,358	227 New	227 $42,000

3,057

409M

7.19M

6.3M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ashburton (Jersey) LTD, based on Form 13F filings with the SEC.

Stay updated on Ashburton (Jersey) LTD with notifications on news.